May 29, 2025 · Ingrezza (valbenazine) is used to treat tardive dyskinesia (TD) and chorea associated with Huntington's disease. Ingrezza uses, side effects, doses, and more.

1. Ingrezza is a medication that is commonly prescribed to patients with ALS (Amyotrophic Lateral Sclerosis) to help manage symptoms such as involuntary movements.

Learn how always once-daily INGREZZA® (valbenazine) capsules can be used to treat tardive dyskinesia (TD). See PI, including Boxed Warning, and Med Guide.

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INGREZZA or INGREZZA SPRINKLE safely and effectively. See full prescribing …

Find treatment guidelines for tardive dyskinesia, including using INGREZZA as a first-line treatment option. See Prescribing Info, including Boxed Warning.

See FAQs about INGREZZA® and treating uncontrollable or involuntary movements (tardive dyskinesia). See PI, including Boxed Warning, and Med Guide.

Oct 1, 2025 · 8.1 Pregnancy - Risk Summary - The limited available data on INGREZZA or INGREZZA SPRINKLE use in pregnant women are insufficient to inform a drug-associated risk.

Medscape - Tardive dyskinesia dosing for Ingrezza, Ingrezza Sprinkle (valbenazine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedule, and …

Oct 23, 2024 · Ingrezza is used to treat certain movement disorder side effects (tardive dyskinesia) that may occur if you have been using antipsychotics for at least 3 months. This is not all the information …

Aug 31, 2023 · Ingrezza (Valbenazine Capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …